Study Stopped
not enough patients to e recruited, problems with the conductance catheter
Mitral Valve Reconstruction in Chronic Heart Failure (CHF): Identification of Predictors for a Successful Therapy
1 other identifier
interventional
5
1 country
1
Brief Summary
The aim of the study is to evaluate hemodynamic and echocardiographic parameters in patients with secondary mitral insufficiency and CHF.
- 1.Identification of hemodynamic parameters as predictor for a successful mitral valve reconstruction in CHF patients.
- 2.Collection of clinical factors for the assessment of the postoperative course after mitral valve reconstruction in CHF patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Jun 2006
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 5, 2006
CompletedFirst Posted
Study publicly available on registry
July 6, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedOctober 27, 2016
May 1, 2009
2.5 years
July 5, 2006
October 25, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identification of hemodynamic parameters as predictor for a successful mitral valve reconstruction in patients with congestive heart failure
3 months
Secondary Outcomes (1)
Identification of clinical factors for the postoperative outcome
3 months
Study Arms (2)
1
ACTIVE COMPARATORSurgical mitral valve reconstruction
2
NO INTERVENTIONconservative treatment
Interventions
Eligibility Criteria
You may qualify if:
- Age \> 18 years old
- Dilatative Cardiomyopathy with LVEF \< 35%
- NYHA III oder IV under maximal medical treatment
- Angiographic and hemodynamic MI \> II° (LAP- mean pressure \> 15-20 mmHg; LA v-wave-oder PCWP v-wave \> 35 mmHg under exercise)
- Echocardiographic MI \> II°
- At least 1 hospitalization for heart failure before OP
You may not qualify if:
- Secondary Cardiomyopathy by vitium cordis
- Planned secondary procedure like CABG, aortic valve surgery, surgery of the tricuspid valve etc
- Euro-Score \> 30%
- Former valve operation or CABG
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Heart Center Leipzig GmbH, University Leipzig
Leipzig, 04289, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gerhard Schuler, Prof.
Chair of the Dep. of Cardiology
- PRINCIPAL INVESTIGATOR
Sven Möbius-Winkler, MD
Consultant of the dep. of Cardiology
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PD Dr. med.
Study Record Dates
First Submitted
July 5, 2006
First Posted
July 6, 2006
Study Start
June 1, 2006
Primary Completion
December 1, 2008
Study Completion
September 1, 2012
Last Updated
October 27, 2016
Record last verified: 2009-05